Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 77.63 Delayed Data As of 4:02pm ET |  -0.76 / -0.97%Today’s Change | 56.59 Today|||52-Week Range 79.44 | +25.11% Year-to-Date |
| ResMed (RMD) at 52-Week High: What's Driving the Stock? Jun 20 / Zacks.com - Paid Partner Content |
| Previous close | 78.39 |
| Today’s open | 78.38 |
| Day’s range | 77.56 - 78.45 |
| Volume | 523,532 |
| Average volume (3 months) | 693,779 |
| Market cap | $11.1B |
| Dividend yield | 1.70% |
| Earnings growth (last year) | +0.81% |
| Earnings growth (this year) | +0.69% |
| Earnings growth (next 5 years) | +10.66% |
| Revenue growth (last year) | +9.52% |
| P/E ratio | 34.0 |
| Price/Sales | 4.87 |
| Price/Book | 6.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| VARVarian Medical Syste... | +0.23 | +0.22% |
| LIVNLivaNova PLC | +0.13 | +0.21% |
| ---- | ||
| NVRONevro Corp | -0.50 | -0.68% |
| Next reporting date | August 3, 2017 |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $1.8B |
| Annual profit (last year) | $352.4M |
| Net profit margin | 19.17% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Mick Farrell |
President & Chief Operating Officer Rob Douglas |
Corporate headquarters San Diego, California |
